Intermediate for Venetoclax. Venetoclax (trade name Venclexta) is a small molecule oral drug that treats chronic lymphocytic leukemia (CLL) in those with a specific chromosomal abnormality. Venetoclax is a BH3-mimetic and acts as a Bcl-2 inhibitor. Venetoclax has been approved by US FDA om April 11, 2016.


Product Name:                  (tetrahydro-2H-Pyran-4-yl)methanamine

Synonyms:                         N/A

CAS Number:                     130290-79-8

Molecular Weight:            115.1748

Molecular Formula:          C6H13NO

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               NCC1CCOCC1


  • $69.00
  • Ex Tax: $69.00

Available Options